Medhat Askar

6PUBLICATIONS
56CO-AUTHORS
Transplantation immunologyHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.

|Jun 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.

Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan

|Aug 21, 2024
Unique Lessons From the Natural Progression of Rejection in Human Uterine Allografts.

Liza Johannesson, Michelle A Wood-Trageser, Drew Lesniak

|Apr 10, 2023
World Marrow Donor Association guidelines for the reporting of novel HLA alleles.

Jan A Hofmann, Werner Bochtler, James Robinson

|Jan 27, 2022
Chimerism analysis for clinicians: a review of the literature and worldwide practices.

Amanda G Blouin, Medhat Askar

|Dec 15, 2021
ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2-specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report.

Katalin Martits-Chalangari, Cedric W Spak, Medhat Askar

Pageof 1

Frequent Collaborators

3 joint publications

Martin Maiers

2 joint publications

Stephen R Spellman

2 joint publications

Karilyn Larkin

2 joint publications

Farhad Khimani